Review Article

An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis

Author(s): Saiedeh Razi Soofiyani, Kamram Hosseini, Alireza Soleimanian, Liela Abkhooei, Akbar Mohammad Hoseini, Vahideh Tarhriz* and Tohid Ghasemnejad*

Volume 10, Issue 3, 2021

Published on: 10 September, 2021

Page: [181 - 190] Pages: 10

DOI: 10.2174/2211536610666210910130828

Price: $65

Abstract

MicroRNAs (miRNAs) are highly conserved non-coding RNAs involved in many physiological processes such as cell proliferation, inhibition, development of apoptosis, differentiation, suppression of tumorigenicity, and regulation of cell growth. The description of the alterations of miRNA expression patterns in cancers will be helpful in recognizing biomarkers for early detection and possible therapeutic intervention in the treatment of cancers. Recent studies have shown that miR-451 is broadly dysregulated in lung cancer and is a crucial agent in lung tumor progression. This review summarizes recent advances in the potential role of miR-451 in lung cancer diagnosis, prognosis, and treatment and provides an insight into the potential use of miR-451 for the development of advanced therapeutic methods in lung cancer.

Keywords: miR-451, lung cancer, biomarker, cancer therapy, diagnosis, prognosis.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy